Total Payments
$12,432
2024 Payments
$65.09
Companies
16
Transactions
59
Medicare Patients
5,690
Medicare Billing
$248,151
Payment Breakdown by Category
Other$9,580 (77.1%)
Food & Beverage$1,528 (12.3%)
Consulting$668.00 (5.4%)
Travel$655.87 (5.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $9,580 | 4 | 77.1% |
| Food and Beverage | $1,528 | 48 | 12.3% |
| Consulting Fee | $668.00 | 2 | 5.4% |
| Travel and Lodging | $655.87 | 5 | 5.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $10,755 | 15 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $828.58 | 6 | $0 (2019) |
| Boston Scientific Corporation | $181.05 | 2 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $117.55 | 8 | $0 (2020) |
| Medtronic Vascular, Inc. | $92.36 | 1 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $77.29 | 5 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $76.97 | 6 | $0 (2018) |
| Kestra Medical Technology Services, Inc. | $65.09 | 2 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $47.10 | 3 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $45.36 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $65.09 | 2 | Kestra Medical Technology Services, Inc. ($65.09) |
| 2022 | $117.43 | 1 | Boston Scientific Corporation ($117.43) |
| 2021 | $89.36 | 3 | Baxter Healthcare ($38.59) |
| 2020 | $14.63 | 1 | Novartis Pharmaceuticals Corporation ($14.63) |
| 2019 | $1,009 | 13 | Merck Sharp & Dohme Corporation ($828.58) |
| 2018 | $5,503 | 15 | Boehringer Ingelheim Pharmaceuticals, Inc. ($5,406) |
| 2017 | $5,634 | 24 | Boehringer Ingelheim Pharmaceuticals, Inc. ($5,349) |
All Payment Transactions
59 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/24/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $16.17 | General |
| Category: Cardiology | ||||||
| 04/13/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $48.92 | General |
| Category: Cardiology | ||||||
| 03/15/2022 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $117.43 | General |
| Category: WATCHMAN_IC | ||||||
| 12/02/2021 | Medtronic, Inc. | Micra (Device) | Food and Beverage | In-kind items and services | $27.77 | General |
| Category: Pacemakers | ||||||
| 03/04/2021 | BRACCO DIAGNOSTICS INC. | Lumason (Drug) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Diagnostic Imaging | ||||||
| 02/01/2021 | Baxter Healthcare | FLOSEAL (Device) | Food and Beverage | In-kind items and services | $38.59 | General |
| Category: Surgical Care | ||||||
| 01/21/2020 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/08/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/20/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/14/2019 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $11.76 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/28/2019 | BRACCO DIAGNOSTICS INC. | CEUS (Drug) | Food and Beverage | Cash or cash equivalent | $22.14 | General |
| Category: CONTRAST MEDIA | ||||||
| 06/17/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.88 | General |
| Category: Cardiovascular | ||||||
| 06/04/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/28/2019 | Merck Sharp & Dohme Corporation | MK-1242 (Drug) | Food and Beverage | In-kind items and services | $48.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/28/2019 | Merck Sharp & Dohme Corporation | MK-1242 (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/28/2019 | Merck Sharp & Dohme Corporation | MK-1242 (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/27/2019 | Merck Sharp & Dohme Corporation | MK-1242 (Drug) | Travel and Lodging | In-kind items and services | $426.94 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/27/2019 | Merck Sharp & Dohme Corporation | MK-1242 (Drug) | Travel and Lodging | In-kind items and services | $212.64 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/27/2019 | Merck Sharp & Dohme Corporation | MK-1242 (Drug) | Food and Beverage | In-kind items and services | $91.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/21/2019 | Medtronic Vascular, Inc. | Reveal LINQ (Device) | Food and Beverage | In-kind items and services | $92.36 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 12/18/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $111.10 | General |
| Category: DIABETES | ||||||
| 10/25/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/31/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/14/2018 | Regeneron Healthcare Solutions, Inc. | PRALUENT ALIROCUMAB INJECTION (Biological) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 07/06/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,395.00 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 19 | 1,865 | 2,392 | $324,447 | $82,897 |
| 2021 | 19 | 2,080 | 2,550 | $346,546 | $88,838 |
| 2020 | 14 | 1,745 | 2,218 | $298,446 | $76,416 |
Total Patients
5,690
Total Services
7,160
Medicare Billing
$248,151
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 137 | 291 | $61,110 | $15,850 | 25.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 249 | 253 | $47,564 | $12,517 | 26.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 74 | 82 | $33,784 | $10,019 | 29.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 113 | 122 | $37,210 | $9,994 | 26.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 51 | 113 | $34,352 | $8,808 | 25.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 664 | 914 | $22,850 | $5,803 | 25.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 57 | 57 | $22,686 | $5,794 | 25.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 25 | 25 | $14,750 | $3,789 | 25.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2022 | 62 | 62 | $14,384 | $3,431 | 23.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 180 | 211 | $15,192 | $1,870 | 12.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $5,137 | $1,206 | 23.5% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2022 | 87 | 88 | $3,872 | $914.50 | 23.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 11 | 11 | $2,519 | $761.53 | 30.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 12 | 16 | $2,368 | $669.63 | 28.3% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Facility | 2022 | 36 | 36 | $2,808 | $488.62 | 17.4% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 12 | 12 | $1,368 | $355.86 | 26.0% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2022 | 18 | 18 | $1,170 | $235.79 | 20.2% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2022 | 11 | 11 | $792.00 | $228.60 | 28.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 37 | 41 | $369.00 | $121.35 | 32.9% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2022 | 18 | 18 | $162.00 | $41.25 | 25.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 151 | 310 | $65,100 | $17,131 | 26.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 198 | 206 | $62,830 | $16,670 | 26.5% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2021 | 248 | 250 | $47,000 | $12,790 | 27.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 58 | 116 | $35,264 | $9,093 | 25.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 66 | 66 | $26,268 | $6,789 | 25.8% |
About Dr. Janet Smith, MD
Dr. Janet Smith, MD is a Cardiovascular Disease healthcare provider based in Louisville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114954625.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Janet Smith, MD has received a total of $12,432 in payments from pharmaceutical and medical device companies, with $65.09 received in 2024. These payments were reported across 59 transactions from 16 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($9,580).
As a Medicare-enrolled provider, Smith has provided services to 5,690 Medicare beneficiaries, totaling 7,160 services with total Medicare billing of $248,151. Data is available for 3 years (2020–2022), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Emergency Medicine
- Location Louisville, KY
- Active Since 06/28/2006
- Last Updated 11/21/2023
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1114954625
Products in Payments
- PRADAXA (Drug) $10,632
- MK-1242 (Drug) $828.58
- JARDIANCE (Drug) $123.85
- ENTRESTO (Drug) $117.55
- WATCHMAN Access System (Device) $117.43
- Reveal LINQ (Device) $92.36
- XARELTO (Drug) $76.97
- Assure WCD (Device) $65.09
- WATCHMAN (Device) $63.62
- PRALUENT (Drug) $54.67
- PRALUENT ALIROCUMAB INJECTION (Biological) $47.10
- ELIQUIS (Drug) $45.36
- FLOSEAL (Device) $38.59
- Micra (Device) $27.77
- Lumason (Drug) $23.00
- MULTAQ (Drug) $22.62
- CEUS (Drug) $22.14
- Vascepa (Drug) $11.67
- ZONTIVITY (Drug) $11.33
- Repatha (Biological) $10.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Louisville
Dr. Dinesh Kalra, Md, MD
Cardiovascular Disease — Payments: $448,244
Cardiovascular Disease $448,244
Jeffrey Stidam, Md, MD
Cardiovascular Disease — Payments: $261,497
Cardiovascular Disease $261,497
John Harris, Md, MD
Cardiovascular Disease — Payments: $250,015
Cardiovascular Disease $250,015
Naresh Solankhi, Md, MD
Cardiovascular Disease — Payments: $176,009
Cardiovascular Disease $176,009
Kent Morris, Md, MD
Cardiovascular Disease — Payments: $151,151
Cardiovascular Disease $151,151
Daniel Rothschild, M.d, M.D
Cardiovascular Disease — Payments: $134,063
Cardiovascular Disease $134,063